- Title
- 857TiP An open-label, multicenter, phase II study of CLR 131 in patients with relapsed or refractory (R/R) select B-cell malignancies (CLOVER-1) and expansion cohort in patients with waldenstrom macroglobulinemia (CLOVER-WaM)
- Creators
- Sikander Ailawadhi - Jacksonville CollegeAsher Chanan-KhanJennifer L. Peterson - Jacksonville CollegePatrick J. Stiff - Loyola University Medical CenterE. Ibrahim - University of RedlandsDamian J. Green - Fred Hutch Cancer CenterJ. Longcor - Cellectar BiosciencesKatherine OliverM.F. Brown - Cellectar BiosciencesJohn Friend - Cellectar BiosciencesNatalie S. Callander - University of Wisconsin–Madison
- Publication Details
- Annals of Oncology, Vol.32
- Publisher
- Elsevier BV; United Kingdom
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Resource Type
- Journal article
- Record Identifier
- 991032007801002976
Journal article
857TiP An open-label, multicenter, phase II study of CLR 131 in patients with relapsed or refractory (R/R) select B-cell malignancies (CLOVER-1) and expansion cohort in patients with waldenstrom macroglobulinemia (CLOVER-WaM)
Annals of Oncology, Vol.32
2021
Metrics
1 Record Views
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites